Pembrolizumab Plus Olaparib in LA-HNSCC

Clinical trial NCT05366166 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05366166
Sponsor: UNC Lineberger Comprehensive Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of Head and Neck

Start date: 2022-09-02
Primary completion: 2027-01-21
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.